Comparing antifungal treatments for hospitalized histoplasmosis patients
Treatments studied
Part of Infections clinical trials.
This trial tests different combinations and timing of antifungal medicines to treat histoplasmosis, a lung infection, in hospitalized patients. It aims to find the safest and most effective way to cure the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently in the hospital due to a suspected histoplasmosis infection
- The histoplasmosis diagnosis has been confirmed by a lab test (like an antigen test or culture)
- You have not had histoplasmosis before
- You are not pregnant or breastfeeding (if applicable)
- Your kidneys are functioning normally (no major kidney problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new antifungal treatment for people with certain fungal infections (Valley fever, blastomycosis, histoplasmosis) who have not done well on or can't take their current medicine. The goal is to find a better way to control the infection when the first treatment fails or causes problems.
This Mayo Clinic study tests whether the oral antifungal drug itraconazole can help people with bronchiectasis who have mold growing in their airways. The goal is to see if it improves symptoms and reduces mold in the lungs.
This Phase 3 trial tests whether a high-dose form of amphotericin B made in tiny fat particles (liposomal amphotericin B) is safer and more effective for treating widespread Histoplasmosis in adults with HIV. It may help people who have a serious, whole-body infection caused by Histoplasma.
This study compares different antifungal medicines to see which works best for a serious lung fungal infection called pulmonary mucormycosis. If you have this infection and haven't had too much prior treatment, you might be able to join.
This study compares two antifungal medications (itraconazole and posaconazole) to see which works better for a chronic fungal lung infection called aspergillosis. If you have this condition, taking part may help control your symptoms and improve your quality of life.
This trial is testing new treatments for cryptococcal meningitis, a serious brain infection, in people living with HIV. It aims to find the best way to treat this infection with fewer side effects.
Hear when a new Histoplasmosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.